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Abstract
Human pluripotent stem cells (hPSCs)—including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs)—are very promising candidates for cell therapies, tissue engineering,
high throughput pharmacology screens, and toxicity testing. These applications require large numbers of high quality cells; however, scalable production of human pluripotent stem cells and their
derivatives at a high density and under well-defined conditions has been a challenge. We recently
reported a simple, efficient, fully defined, scalable, and good manufacturing practice (GMP) compatible 3D culture system based on a thermoreversible hydrogel for hPSC expansion and differentiation. Here, we describe additional design rationale and characterization of this system. For instance,
we have determined that culturing hPSCs as a suspension in a liquid medium can exhibit lower
volumetric yields due to cell agglomeration and possible shear force-induced cell loss. By contrast,
using hydrogels as 3D scaffolds for culturing hPSCs reduces aggregation and may insulate from
shear forces. Additionally, hydrogel-based 3D culture systems can support efficient hPSC expansion
and differentiation at a high density if compatible with hPSC biology. Finally, there are considerable
opportunities for future development to further enhance hydrogel-based 3D culture systems for producing hPSCs and their progeny.
Keywords: Human embryonic stem cells, Induced pluripotent stem cells, 3D culture system,
Thermoreversible hydrogel.

Introduction
Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs)35
and induced human pluripotent stem cells (hiPSCs),34 are being investigated for a broad
range of biomedical applications because of their unique characteristics. Not only can they
undergo effective long-term expansion in vitro to yield large quantities of cells, but they
can also be differentiated into presumably all cell types in the adult body.5 Thus, they are
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promising candidates in cell replacement therapies for various human degenerative diseases
or injuries,18,28 for generating engineered tissues or organs,2 and for drug discovery and toxicity testing.7,20
All of these applications require a large number of cells.2,7,20,28 In particular, the patient
populations with degenerative diseases/injuries or organ failure are large, with for example
~ 8 million patients with myocardial infarction (MI), ~1–2.5 million with type I diabetes, and
~1 million with Parkinson’s disease (PD) in the US alone.27,29 In addition, to treat an individual with MI, type I diabetes, or PD, approximately 109 surviving cardiomyocytes, 109 b
cells, or 105 dopaminergic (DA) neurons are required, respectively.29 Furthermore, due to the
low survival of transplanted cells in vivo (e.g. ~6% DA neurons or 1% cardiomyocytes have
survived several months after transplantation in rodents 14,15), even more cells will be necessary in reality. In addition, tissue engineering endeavors would require ~109 hepatocytes or
cardiomyocytes to create an engineered human liver or heart, respectively.2 Finally, for drug
discovery, ~1010 cells are necessary to screen a library with a million compounds,7 and there
are many large chemical, peptide, and nucleotide libraries that can be screened against many
types of cells derived from hPSCs.41 In summary, a substantial number of hPSCs are necessary for current and future research and development.
Current strategies for producing hPSCs or their derivatives at a large scale generally involve three steps.29 First, a working cell bank containing many hPSC aliquots is established
and cryopreserved. Second, an aliquot is grown into the desired number of cells through a
series of expansions. Finally, these cells are then differentiated into the targeted cell types.
An efficient and scalable bioprocess is required for both the expansion and differentiation.
In addition, if the cells are being produced for clinical application, the bioprocess must comply with good manufacturing practices (GMP).36 Currently, the most widely used systems
involve the expansion and differentiation of hPSCs on 2D surfaces. Though significant advances have resulted in increasingly well-defined 2D culture systems (including a range of
media and substrates), the production of cells on a large scale remains a challange.29,38 For
instance, at a typical density of ~5000 DA neurons/cm2 or ~50,000 cardiomyocytes/ cm2,
~0.5 km2 or 16 km2 of cell culture surfaces are necessary to contain sufficient numbers of
DA neurons or cardiomyocytes to treat PD or MI populations in the US, not to mention the
surface area required to expand the parent hPSCs.
Thus, it may be desirable, and even unavoidable, to move from 2D to 3D for the largescale hPSC production.19,29 A number of 3D suspension culture systems have been investigated for hPSC culture during the past decade. Single or small clumps of hPSCs have been
suspended and cultured as cell aggregates in liquid medium under continuous stirring or
shaking.1,6,32,42 Alternatively, hPSCs have been first seeded onto polymeric microspheres
coated with matrix proteins and then cultured as a microcarrier suspension in a liquid medium.4,22 While these 3D systems have achieved some degrees of success, many challenges
have also been reported.17 In particular, considerable cell agglomeration, which can lead to
cell death or uncontrolled differentiation, is frequently observed in suspension cultures.4,17,32
Apoptosis induced by shear forces resulting from the medium flow is also common.1,4,6,22,32,42
As a result of such constraints, suspension systems often use low initial seeding densities
and result in relatively low cell expansion and volumetric cell yields.17,29 Encapsulating and
culturing small clumps of hPSCs in a number of hydrogels have also been studied.3,10,30,33
However, limited cell growth has been achieved to date, and uncontrolled differentiation
can occur in such 3D culture systems.17,29 In short, costeffective production of hPSCs or their
derivatives on a large scale and under well-defined conditions is very challenging.
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An efficient 3D culture system for large-scale hPSC production should exhibit a number
of features. First, it should support a high density hPSC culture at a high cell growth rate.
Culturing hPSCs at a high density can significantly reduce the space, labor, and material
necessary for cell expansion, and is thus highly desirable for large-scale hPSC production.
Likewise, the cell growth rate should be close or equal to the highest rate achieved on 2D
surfaces. Second, the system should be well-defined such that production is reproducible
and compatible with GMP. Third, the system should be simple, scalable, and easy to automate. Finally, it would be desirable to support single cell seeding to ‘‘synchronize’’ the
environmental conditions that cells experience. While research has shown that cell dissociation promotes hPSC apoptosis,23 single cell seeding offers the potential for more uniform
and reproducible expansion and differentiation.8,13,21
We recently developed and reported a simple, welldefined, efficient, scalable 3D culture
system, utilizing a thermoreversible hydrogel as a biomaterial scaffold, for both hPSC expansion and differentiation at high density.17 In this paper, we describe additional characterization of the system as well as general design rationale for 3D systems that enable hPSC
culture at a high density. Briefly, we found that under a typical set of conditions, we were
unable to culture hPSCs as a suspension in a liquid medium with high volumetric yields.
Substantial cell agglomeration was observed in these suspension cultures. The use of hydrogels as 3D scaffolds for hPSC culture was able to mitigate cell aggregation, and such
scaffolds may also isolate cells from shear forces that accompany cell culture agitation and
can lead to cytotoxicity.1,4,6,22,32,42 Finally, the ability to adapt this system to also support
cell differentiation—such as into neural lineages—is a useful feature, and future work may
further enhance the ability of the system to promote economical cell expansion as well as
differentiation into additional lineages.
Materials and Methods
Reagents
hESC lines H1 and H9 were obtained from WiCell Research Institute. iPS-MSC25 (derived
from human mesenchymal stem cells) and iPS-Fib225 (derived from human dermal fibroblasts) were a kind gift from George Q. Daley at Children’s Hospital Boston. Essential 8
medium (E8),5 0.5 mM EDTA, Accutase, ProLong® Antifade reagents, LIVE/DEAD® Cell
Viability staining kit, Click-iT® EdU Alexa Fluor® 594 Imaging Kit and Alkaline Phosphatase Live Stain kit were obtained from Life Technologies. Small molecules Y-27632 (ROCK
inhibitor, or RI), SB431542, and LDN193189 were from Selleckchem. Matrigel was obtained
from BD Biosciences. PNIPAAm-PEG polymer (Mebiol Gel) was from Cosmo Bio, USA.
SCID Beige mice were from Charles River Laboratory. Finally, the following antibodies and
dilutions were used: Oct4 and Nanog (Santa Cruz Biotech, 1:100); FOXA2 or HNF3b (Santa
Cruz Biotech, 1:200); Nestin (Millipore, 1:200); aSMA (Abcom, 1:200).
Expanding hPSCs in Suspension in Liquid Medium
hPSCs maintained on Matrigel-coated plates were incubated with Accutase at 37 °C for 5
min and dissociated into single cells. Single hPSCs were then suspended in mTeSR or E8
medium in low adhesion plates. For dynamic cell cultures, the plate was shaken at 70–90
rpm. To change medium, cells were spun down at 300 g for 3 min before replacing the old
medium with fresh medium.
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FIGURE 1. 3D static suspension culture. Single iPS-Fib2s were cultured for 4 days in static liquid culture with
mTeSR or E8 medium and RI (present for the full 4 days) at low, medium, or high seeding density (2.5 3 105, 1.0
3 106, or 2.5 3 106 cells/mL, respectively). (a and b) Cell morphologies on day 1, 2, 3, and 4 are shown with phase
contrast images. (c, d and e) Mean diameter of the hPSC aggregates, fold expansion and cell densities at different
days within the 4 days culture period. ***indicates statistical significance at a level of p < 0.001. Scale bar: 250 lm.
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FIGURE 2. 3D dynamic suspension culture. Single iPS-Fib2s were cultured in liquid medium for 4 days in
mTeSR or E8 with 4 days of RI at low, medium, or high seeding density (2.5 3 105, 1.0 3 106, or 2.5 3 106 cells/
mL, respectively) under 75–90 rpm shaking. (a and b) Cell morphologies on day 1, 2, 3, and 4 are shown with
phase contrast images. (c, d and e) Mean diameter of the hPSC aggregates, fold expansion and cell densities at
intermediate times within the 4 days culture. ***indicates statistical significance at a level of p<0.001. Scale bar:
250 lm.
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Expanding hPSCs in HA, Agarose, or Alginate Hydrogels
Hyaluronic acids (60–90 kDa, Lifecore, #HA60 K-1) were modified with acrylates and crosslinked via UV with 0.05% Irgacure 2959 and cells.10,16 The agarose hydrogel was made from
low melting temperature agarose (Lonza, #50080).33 The alginate hydrogel was prepared by
extruding alginate (Sigma, #A2033) solution with cells into 100 mM CaC l2 3,30 Cells were
encapsulated and cultured for 4 days in medium supplied with ROCK inhibitor for 24 h or
4 days. On day 4, live/dead cell staining was performed.
Expanding hPSCs in Thermoreversible Hydrogels
Single cells were mixed with 10% ice-cold PNIPAAm-PEG solution that was then cast on
tissue culture plates and incubated at 37 °C for 15 min to form hydrogels. To passage hPSCs,
the medium was removed, and the gel was dissociated and dissolved with ice cold PBS for
2 min. Spheroids were collected, incubated with Accutase at 37 °C for 10 min, and dissociated into single cells. Cells were counted with the NucleoCounter NC-200 (Chemometec).
Staining and Imaging
Cells on 2D surfaces were fixed with 4% paraformaldehyde (PFA) for 15 min, permeabilized
with 0.25% Triton X-100 for 15 min, pre-blocked with 5% goat serum for 1 h, then incubated
with primary antibodies for 2 h. After 3 washes with PBS, they were incubated with secondary antibodies in 2% BSA for 1 h. After 3 washes with PBS, cells were imaged. hPSC spheroids were fixed with 4% PFA for 30 min, incubated with PBS + 0.25% Triton X-100 + 5% goat
serum + primary antibodies overnight. After 3 washes with PBS, spheroids were incubated
with secondary antibodies in 2% BSA for 4 h. After 3 washes with PBS, cells were mounted
with ProLong® Antifade reagent and imaged. All procedures were conducted at room temperature. Live/dead staining, EdU pulse labeling, and alkaline phosphatase staining were
conducted with the LIVE/DEAD® Cell Viability staining kit, Click-iT® EdU Alexa Fluor®
594 Imaging Kit, and Alkaline Phosphatase Live Stain kit, respectively.
Embryoid Body (EB) Differentiation
Single hPSCs were suspended in liquid medium in low adhesion plates for 6 days to form
EBs, which were then plated on gelatin-coated plate and cultured for another 6days before
fixation and staining. DMEM + 20% FBS + 10 lM b-mercaptoethanol were used for the EB
differentiation.
Teratoma Assay
The teratoma assay was approved by the Animal Care and Use Committee of the University
of California, Berkeley. 5.0 9 106 hPSCs were suspended in 50 lL 50% Matrigel and injected
subcutaneously in SCID Beige mice. Teratomas were harvested after 6–12 weeks; fixed with
4% PFA for 48 h; dehydrated with 70, 95, 100% ethanol and xylene sequentially; and embedded in paraffin. 10 lm thick sections were cut and stained with hematoxylin and eosin. All
procedures were conducted at room temperature.
Statistical Analysis
Statistical analyses were conducted using the statistical package Instat (GraphPad Software,
La Jolla, CA). For multiple comparisons, the means of triplicate samples were compared
using the Tukey multiple comparisons analysis with the alpha level indicated in the figure
legend.
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FIGURE 3. Culturing iPS-Fib2s in various hydrogels withc mTeSR or E8 and RI at medium seeding density.
Cells were encapsulated and cultured for 4 days. Medium was supplied with RI for 24 h or 4 days. On day 4,
live/dead cell staining was conducted to evaluate the viability. (a) Phase contrast images and live dead cell
staining showing the cell morphologies and viability. (b and c) Fold expansion and final cell density for hPSCs
over day 4 in various hydrogels. ***indicates statistical significance at a level of p < 0.001. Scale bar: 250 lm.
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FIGURE 4. Expanding hPSCs in the 3D thermoreversible hydrogel. Single hPSCs were encapsulated and
cultured in 10% PNIPAAm-PEG hydrogel in E8 with RI for 5 days with daily medium change. (a) Phase
contrast images showing the growing spheroids on day 1, 3, 4, and 5 within the hydrogel. (b) Live/dead cell
staining revealed that the majority of cells were viable, and (c) uniform EdU pulse labeling was seen across the
spheroid. Spheroids on day 5 are shown in (b, c). The majority of cells in the spheroids expressed the pluripotency markers alkaline phosphatase (d), as well as Oct4 and Nanog (e). Quantification of the expansion (f), cell
density (g), and Oct4 and Nanog (h) expression during a 5 days culture. (i) Long term, serial expansions of
iPS-Fib2, iPS-MSC, and H9 cells could be achieved in the 3D thermoreversible hydrogel. The fold expansion at
passages 1, 5, 15, 25, and 35 are shown. Passaging was conducted every 5 days. (j) EB differentiation in vitro.
iPS-Fib2s were expanded in the 3D hydrogel for 25 passages and harvested for EB differentiation. Expression
of markers indicating differentiation into the three germ layers (e.g. ectoderm: Nestin; mesoderm: aSMA;
and endoderm: HNF3b) were found. (k) Teratoma formation in vivo. iPS-Fib2s were expanded in the 3D
hydrogel for 25 passages and har- vested for teratoma analysis. Structures from all 3 germ layers (e.g. ectoderm:
epidermis; mesoderm: muscle; and endo- derm: gut-like-structure) (arrows) were found in tissue sec- tions with
hematoxylin and eosin staining. (l) iPS-Fib2s were cultured in the 3D gel for 10 passages and replated on 2D
surfaces. Phase contrast image (1d) and Oct4 staining (4d) for iPS-Fib2s on 2D surfaces are shown. Scale bar: (b,
c) 50 lm, (d, e, k) 100 lm and (j, l) 200 lm.
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Results and Discussion
3D Expansion of hPSCs in Static and Dynamic Liquid Cultures
The expansion and differentiation of hPSCs at high density offers the potential to provide uniform culture conditions for large numbers of cells, and to reduce production
costs.17 The 3D suspension cultures previously reported represent significant advances
over prior practice, though they have typically utilized low initial seeding densities and
resulted in limited final volumetric cell yields.17,29 Some of these 3D systems reached relatively high cell yields, but had other problems, such as slow cell growth, using undefined
medium, or uncontrolled differentiation.17,29 To assess final cell density in suspension
cultures, single iPSFib2s (iPSCs derived from human dermal fibroblasts) were cultured
as a suspension in broadly used mTeSR or in the well-defined Essential 8 medium (E8).
Cell passaging and seeding as small clusters were previously described.17 These experiments were performed in the absence and presence of ROCK inhibitor (RI), which was
either added during the first 24 h or during the entire culture period (4 days). In addition,
three initial seeding densities—2.5 9 105 (low), 1.0 9 106 (medium), and 2.5 9 106 cells/mL
(high)—were tested. Finally, the culture was either maintained under static conditions
(static suspension culture, Fig. 1) or shaken at a low speed (75-90 rpm, dynamic suspension culture, Fig. 2).
For both the static and dynamic liquid cultures, the addition of RI was crucial to the
survival and expansion of hPSCs in suspension culture as demonstrated by the observation that no hPSCs survived after 4 days in the absence of RI (data now shown). No
significant differences were observed in the final cell yields for the static or dynamic cultures grown in the presence of RI, either during the first 24 h (data not shown) or during
the entire 4 days, which indicates that RI is only important for the survival and expansion of the initial single hPSCs. It should also be noted that the hPSCs quickly associated
to form small spherical aggregates in the suspension cultures.
Under static conditions at a low seeding density in liquid suspension culture, the cell
number exhibited an increase on day 3 followed by a slower increase on day 4, resulting in a ~3.0-fold total expansion by day 4 with a final cell density at ~0.75 9 106 cells/
mL (Fig. 1). After the first 2 days of such cultures, spheroids were relatively small and
uniform. However, large aggregates were observed as the cell density approached 1.0 9
106 cells/mL on day 3 and 4 (Figs. 1a–1c). Under static conditions at a medium seeding
density, the cell number was constant during the 4 days, indicating that either no cell
growth occurred or that cell growth was equal to cell death (Figs. 1d, 1e). Considerable
cell agglomeration was observed from day 2–4 (Figs. 1a–1c). Similarly, under static conditions at a high seeding density, excessive agglomeration and a progressive decrease in
cell number were observed from day 1 to day 4, resulting in a final cell density of ~1.25
9 106 cells/mL (Fig. 1). In all cases for static conditions, there were no significant differences between the mTeSR and E8 media (Fig. 1).
The use of dynamic conditions significantly reduced the level of cell agglomeration,
especially at the low or medium seeding densities (Figs. 2a–2c), presumably due to shear
forces either preventing aggregation or dissociating aggregates above a certain size.13
Severe cell agglomeration was still observed for the culture with a high seeding density
(Figs. 2a–2c). Under dynamic conditions at a low seeding density, cell number increased
linearly during the 4 days, resulting in a ~4.0-fold final expansion and a final density
of ~1.0 9 106 cells/mL (Figs. 2d, 2e). In the case of the medium seeding density, a slight
increase in the cell number was observed, resulting in a final density of ~1.25 9 106 cells/
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mL (Figs. 2d, 2e). Finally, at high seeding density, the cell density decreased to ~1.25 9 106
cells/mL at end of the 4 days period (Figs. 2d, 2e). Again, no significant differences were
observed when mTeSR or E8 was used as the medium.
In summary, hPSCs tend to aggregate due to strong cell–cell interactions.31 Culture
agitation can reduce cell agglomeration but under the conditions explored here does not
dramatically improve the cell yield. Regardless of the initial seeding density, the final
volumetric yield for static or dynamic 3D suspension culture was ~1.0–1.5 9 106 cells/mL
(Figs. 1, 2). Thus, complementary approaches should be explored to achieve high hPSC
densities.
Expanding hPSCs in Hydrogels
It is possible that encompassing hPSCs within a physical medium or barrier may prevent
excessive cell agglomeration and isolate hPSCs from shear forces generated by medium
flow. Based on prior literature that encapsulated hESCs within several materials, we investigated whether hydrogels could enable high density cultures or support single hPSCs
in mTeSR or the well-defined E8 medium, and in the presence of RI. Chemically crosslinked hyarulonic acid (HA),10,16 physically associated agarose,33 and ionically associated
alginate hydrogels were 3,30prepared as described. In HA hydrogels, no cell expansion
or spheroids were observed under the conditions and liquid medium used, and the majority of cells were nonviable on day 4 (Fig. 3). In agarose hydrogels, most of the cells
remained viable, but no cell expansion or spheroid formation was observed here (Fig. 3).
Finally, significant cell death was observed in alginate hydrogels when the RI was only
present during the first 24 h in either mTeSR or E8 media. However, while only sporadic
spheroids were observed in the hydrogel with mTeSR, a significant number of spheroids
formed in this hydrogel in the presence of the E8 medium when RI was supplied for 4
days. In short, these hydrogels successfully prevented cell agglomeration; however, cell
growth in these gels under the defined conditions used was limited.
While the properties of the materials varied substantially, several suggestions may be
gleaned from this experiment (Fig. 3). First, hPSCs grew better in the physically or ionically associated hydrogels that were tested here. The storage modulus for the HA, agarose, and alginate hydrogels was 3600, 3111, and 2100 Pa, respectively.17 In addition to
being slightly softer, the latter physically associated gels may also offer cells the capacity
to forcibly rearrange the gel during cell and spheroid expansion. Second, compared with
mTeSR, the well-defined E8 medium supports better hPSCs growth in hydrogels. Third,
supplying RI for the first 24 h is insufficient to support the survival and proliferation of
single hPSCs in such materials. However, the fact that a ~3.0-fold expansion was achieved
in the alginate hydrogel with the E8 medium and 4 days RI suggests that some hydrogels
may be promising as scaffolds for hPSC culture (Fig. 3). It may thus be worthwhile to
explore additional hydrogel materials.
Expanding hPSCs in Thermoreversible Hydrogels
We investigated the use of thermoreversible hydrogels as scaffolds for 3D hPSC culture.
Thermoreversible hydrogels have the following features that make them attractive for
the 3D hPSC culture: (A) they can be synthetically generated on a large scale to enhance
reproducibility and reduce material costs; (B) they can be chemically well-defined and
thus compatible with GMP; (C) they can be biocompatible and have low cytotoxicity;
(D) they rapidly respond to temperature changes, which makes it possible to harvest or
passage cells by simply changing the temperature from 4 to 37 °C; and (E) they can be
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processed into fibers or spheres through extrusion or emulsion for suspension culture
in large bioreactors. We studied a number of ‘‘home-made’’ and commercially available
thermoreversible hydrogels in a prior study,17 and additional results reported here indicate
that the 6–10% PNIPAAm-PEG hydrogels (Mebiol Gel) are able to support the survival,
proliferation and pluripotency of single hPSCs.
6–10% aqueous PNIPAAm-PEG solutions exhibit low viscosity, allowing for facile and
homogenous mixing with cells. In particular, they form soft and elastic hydrogels with
G¢ in the range of 300–1000 Pa upon heating to 22 °C within 5 min,17 and they can be reliquefied by cooling to 4 °C within 5 min in the culture conditions we used. As with the
prior materials, we observed that hPSC growth is sensitive to the duration of RI presence
and the type of medium. No cell growth was found when RI was added for only the first 24
h. However, with the 4 days RI treatment, a 2or 10-fold expansion was achieved in mTeSR
or E8 medium, respectively (Fig. 3). After a systematic optimization with using a factorial
designed experiment as we recently reported,17 a system with a 8-10%PNIPAAm-PEG,
well-defined E8, a 4 days RI treatment, and a medium seeding density were found to support approximately a 10.0or 20.0-fold cell expansion in a single 4 days or 5 days passage,
with doubling times (~27.7 h) close to that on 2D surfaces (~27.0 h).
Using this optimized system, single hPSCs rapidly expanded and formed uniform
spheroids without cell agglomeration (Fig. 4a). In addition, live/dead cell staining revealed that the majority of cells in the gel were viable (Fig. 4b). Also, uniform EdU pulse
labeling was observed within spheroids, indicating efficient mass transport (e.g., nutrients,
growth factors, and O2) within the hydrogel and the spheroids (Fig. 4c). Furthermore, the
majority of cells in the gel expressed pluripotency markers, such as alkaline phosphatase,
Oct4, and Nanog (Figs. 4d, 4e). We also found this system could support long-term culture
for multiple hPSC lines, including iPS-Fib2s, iPS-MSCs, and H9s (H1 cells growth slightly
slower17). Over a 5 days culture of such cells, the hPSCs exhibited a ~1.0, 2.5, 6.0, 10.0,
and 20.0-fold expansion over day 1, 2, 3, 4, and 5, respectively (Fig. 4f), resulting a final
density of ~2.0 9 107 cells/mL (Fig. 4g). Importantly, consistent ~20.0-fold expansions were
achieved for each passage (5 days) during long-term serial expansion (Fig. 4i), and both
Oct4 and Nanog expression was maintained at ~95% during the culture (Fig. 4h). Lastly, no
significant differences in performance were observed between these 3 cell lines.
Finally, we assessed functional maintenance of pluripotency using in vitro EB differentiation and in vivo teratoma formation. Endodermal (HNF3b), mesodermal (aSMA), and
ectodermal (Nestin) markers were observed in all EB differentiations from the three cell
lines following 25 passages in the 3D hydrogel system (Fig. 4j). In addition, all hPSC lines
formed teratomas in vivo, including epidermis from the ectoderm, muscle from the mesoderm, and gut-like structure from the endoderm (Fig. 4k). Moreover, karyotypes were
normal for these hPSCs after longterm culture within the gel.17 hPSCs cultured in the 3D
hydrogel for long term could also be returned to conventional 2D surfaces (Fig. 4l). Finally,
we the 3D culture system can efficiently support directed differentiation into multiple cell
types.17
Conclusions
In summary, we developed a simple, well-defined and scalable 3D culture system for
rapid hPSC expansion and efficient differentiation at high densities.17 When cultured
as a suspension in liquid medium under the reported conditions, there was a limit
to the maximum volumetric cell yield that could be achieved due to substantial cell
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agglomeration and potential shear force induced cell apoptosis.8,13,21 In contrast, the
use of hydrogels as scaffolds for the hPSC culture can prevent cell agglomeration and
may isolate cells from shear forces.
However, to achieve efficient hPSC expansion at a high density, a hydrogel-based
3D system (including the scaffold and the medium) must not only overcome engineering challenges, but also support certain aspects of hPSC biology.17 For example, both
hESCs and iPSCs are epiblast-like pluripotent stem cells whose survival and proliferation depends on multiple extracellular cues.20,23 Soluble protein factors, such as
FGF2 and TGF-b, signal through a variety of pathways to support their survival, proliferation, and pluripotency.12,37,39 Integrin-mediated cell–matrix interactions are also
important.40Likewise, cadherin-mediated cell–cell contacts are key for hPSC survival
and proliferation.23,24 Dissociating hPSC colonies into single cells as a result leads to
Abr-dependent RhoA and ROCK activation, followed by downstream actomyosin hyperactivation and apoptosis.23,24 Other environmental stresses (e.g. mechanical forces
11,29and redox conditions 5) can also impact their function.
To support cell viability and growth, a number of conditions were required. RI
was necessary during the entire culture period to prevent the dissociationinduced cell
death for single cultured hPSCs. In addition, physically associated and soft hydrogels may enable the force generated by the expanding hPSCs to deform the scaffold
to create sufficient space for the growing cells. Furthermore, the hydrogel should be
sufficiently porous to support efficient transport of nutrients, O2, and protein factors.
Finally, the welldefined E8 medium may be favorable for expansion, as b-mercaptoethanol in mTeSR medium may negatively interact with 3D growth in the scaffold via
unknown mechanisms, resulting in additional stresses that inhibit hPSC survival and
proliferation.17
The reported system demonstrates promising results for the large-scale hPSC expansion and differentiation. In addition, future work will enable further enhancement
of hPSC expansion and differentiation at various scales. First, characterization of the
molecular mechanisms by which the 3D culture system enhances hPSC survival and
rapid growth may enable additional improvement. Second, the system was shown to
support the expansion and differentiation of 4 hPSC lines,17 and additional work will
extend its utility to further lines such as patient-specific iPSCs and potentially also
adult stem cells. Also, numerous protocols are being developed for the directed differentiation of hPSCs into various cell types, and these can potentially be adapted to
3D culture. Third, enhancing cell culture economics will further benefit the system.
hPSC expansion and differentiation media contain multiple, costly recombinant protein factors, and identifying small molecule substitutes or engineering systems for
higher potency protein factor presentation can be pursued to reduce the cost. Fourth,
processing thermoreversible hydrogels into formats that can be suspended in a liquid
medium—such as spheres or fibers—will be necessary to incorporate these hydrogels
into various types of existing or new bioreactors for the large-scale production of
hPSCs or their derivatives, including automated bioreactors with hydrogels. Finally,
hPSC biology is a rapidly evolving field, and this modular system (the material and
the medium) can evolve in parallel to harness this new knowledge.9 We thus anticipate that thermoreversible hydrogel systems can contribute to resolving significant
challenges that currently limit the use of hPSCs in many biomedical applications.
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